Brooks Laboratories has informed that, pursuant to the Regulation 30 read with Schedule III of the Listing Regulations, the Company has sent communication through RTA vide speed post to all the shareholders holding shares in physical form for furnishing PAN, KYC details and nomination etc. in terms of SEBI Circular No. SEBI/HO/MIRSD/MIRSD-PoD-1/P/CIR/2023/37 dated 16th March 2023.
The above information is a part of company’s filings submitted to BSE.